Universal Health Services, Inc.

NYSE:UHS

Medical - Care Facilities

Healthcare
$186.07 -3.84%

-$5.64 today

Market cap
$9.38B
Beta
1.08
P/E (TTM)
5.7
EPS (TTM)
$24.90
Dividend yield
0.57%
52W Low $140.08High $246.33

Volume 0.67M

Average 0.94M

UHS Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Universal Health Services, Inc.NYSE: UHS

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue grows, but more slowly than its trailing trend

Q2 FY2026 cost of revenue of $423.26M rose 1.1% year over year, behind the +4.3% change in trailing-twelve-month cost of revenue. Sequentially, it fell 0.8% from the prior quarter. Over 3 fiscal years it compounded at +4.0% a year.

Context

  • Cost of revenue amounted to 9.6% of revenue in FY2025, down 0.5 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +1.1% toward the trailing-twelve-month pace of +4.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$423.26M-0.8% QoQ
Last fiscal yearDec 2025
$1.66B+4.5% YoY
LTMJun 2026
$1.69B+4.3% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.1%——
1 year+4.5%——
3-year CAGR+4.0%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
1.66B USD
Year-over-year change
+4.5%
4-year CAGR
+3.8%

Cost of Revenue vs competitors

How UHS compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +4.3% is the 8th highest of 9, against a peer median of +39.8%.
  • Cost of revenue amounts to 9.3% of revenue for UHS, versus a peer median of 66.1%.
UHS Competitors
Cost of Revenue for UHS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HCAHCA Healthcare, Inc.LTM Jun 2026$55.89B USD+30.1%+6.1%71.6%
THCTenet Healthcare CorporationLTM Jun 2026$15.95B USD+100.3%-32.2%73.1%
FMSFresenius Medical Care AG & Co. KGaALTM Jun 2026€14.31B EUR-2.7%+0.2%73.6%
CYHCommunity Health Systems, Inc.LTM Mar 2026$9.96B USD+35.0%+16.0%46.3%
ARDTArdent Health Partners, LLCLTM Mar 2026$3.23B USD+127.0%-45.4%50.3%
ACHCAcadia Healthcare Company, Inc.LTM Sep 2026$2.14B USD+252.6%+200.9%62.7%
CHEChemed CorporationLTM Jun 2026$1.81B USD+8.3%+9.0%69.6%
UHSUniversal Health Services, Inc.LTM Jun 2026$1.69B USD+4.3%+4.0%9.3%
NUTXNutex Health, Inc.LTM Mar 2026$462.28M USD+44.5%+28.3%52.5%
Peer median (excluding UHS) —+39.8%+7.5%66.1%

Competitors are the stored peer set for UHS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue12.64B13.4B14.28B15.83B17.36B
Cost of Revenue1.43B1.47B1.53B1.59B1.66B
Gross Profit11.21B11.93B12.75B14.24B15.71B
Gross Margin88.7%89.0%89.3%90.0%90.4%
Research & Development00000
Selling, General & Admin6.28B6.89B7.25B7.67B8.23B
Operating Expenses9.85B10.92B11.57B12.56B13.71B
Depreciation & Amortization533.21M581.86M568.04M584.83M618.74M
EBITDA1.91B1.58B1.72B2.27B2.74B
EBITDA Margin15.1%11.8%12.0%14.3%15.8%
Operating Income1.36B1B1.18B1.68B1.99B
Operating Margin10.8%7.5%8.2%10.6%11.5%
Interest Income1.6M378K572K1.43M1.19M
Interest Expense85.27M127.27M207.25M187.53M157.26M
Other Income / Expenses(69.78M)(137.3M)(234.96M)(183.88M)(21.87M)
Income Before Tax1.29B866.26M940.43M1.5B1.97B
Pre-Tax Margin10.2%6.5%6.6%9.5%11.4%
Income Tax Expense305.68M209.28M221.12M334.83M460.96M
Net Income991.59M675.61M717.8M1.14B1.49B
Net Margin7.8%5.0%5.0%7.2%8.6%
EPS (Basic)11.999.2310.3517.1623.42
EPS (Diluted)11.829.1410.2316.8223.10
Weighted Avg Shares82.52M73.12M69.32M66.55M63.58M
Weighted Avg Shares (Diluted)83.69M73.83M70.13M67.9M64.46M

Universal Health Services, Inc.

NYSE:UHS

Intrinsic Alpha fair value

Locked

Current Price

$186.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.